XML 25 R9.htm IDEA: XBRL DOCUMENT v3.21.2
Shareholders' Equity
12 Months Ended
Mar. 31, 2021
Stockholders' Equity Note [Abstract]  
Shareholders' Equity

3. Shareholders’ Equity

 

Stock Option Plans. We have a stock option plan, the 2007 Stock Option Plan, and we adopted our 2014 Equity Incentive Plan (the “Plan,” as summarized below) to promote our and our shareholders’ interests by helping us to attract, retain and motivate our key employees and associates. Under the terms of the Plan, the Board of Directors may grant incentive and non-qualified stock options, stock appreciation rights, restricted stock, restricted stock units, performance units, and other stock-based awards. The purchase price of the shares subject to a stock option will be the fair market value of our common stock on the date the stock option is granted. Generally, vesting of stock options occurs such that 20% becomes exercisable on each anniversary of the date of grant for each of the five years following the grant date of such option. Generally, all stock options must be exercised within five years from the date granted. The number of common shares reserved for issuance under the Plan is 1,100,000 shares of common stock, subject to adjustment for dividend, stock split or other relevant changes in our capitalization.

 

Under ASC 718, the value of each employee stock option was estimated on the date of grant using the Black-Scholes model for the purpose of financial information in accordance with ASC 718. The use of a Black-Scholes model requires the use of actual employee exercise behavior data and the use of a number of assumptions including expected volatility, risk-free interest rate and expected dividends. Employee stock options for 110,000 and 185,000 shares of stock were granted during fiscal years 2021 and 2020, respectively.

 

As of March 31, 2021, $73,000 of total unrecognized compensation costs related to nonvested stock is expected to be recognized over a period of five years. The assumptions for employee stock options are summarized as follows:

 

Years Ended   March 31, 2021   March 31, 2020
Risk-free interest rate     0.3% to 0.4%       1.2% to 2.4%  
Expected life (in years)     5.0       5.0  
Expected volatility     87%       87% to 89%  
Expected dividend     0%       0%  

 

Cumulative compensation cost recognized in net income or loss with respect to options that are forfeited prior to vesting is adjusted as a reduction of compensation expense in the period of forfeiture. The volatility of the stock is based on the historical volatility for the period that approximates the expected lives of the options being valued. Fair value computations are highly sensitive to the volatility factor; the greater the volatility, the higher the computed fair value of options granted.

 

The total fair value of options granted was computed to be approximately $40,000 and $62,000, for the fiscal years ended March 31, 2021 and 2020, respectively. For disclosure purposes, these amounts are amortized ratably over the vesting periods of the options. Effects of stock-based compensation, net of the effect of forfeitures, totaled $33,354 and $30,708 for fiscal years 2021 and 2020, respectively.

 

The Black-Scholes model was developed for use in estimating the fair value of traded options that have no vesting restrictions and are fully transferable. In addition, option valuation models require the use of assumptions, including the expected stock price volatility. Because our employee stock options have characteristics significantly different than those of traded options, and because changes in the subjective input assumptions can materially affect the fair value estimate, in management’s opinion, the existing models do not necessarily provide a reliable single measure of the fair value of our employee stock options. A summary of our stock option activity and related information for equity compensation plans approved by security holders for each of the fiscal years ended March 31, 2021 and 2020 is as follows:

 

          STOCK OPTIONS OUTSTANDING  
         

Number

Outstanding

      Weighted-Average Exercise Price per Share  
  BALANCE AT MARCH 31, 2019       672,000     $ 0.43  
  Granted       185,000       0.42  
  Forfeited/expired       (103,000 )     0.71  
  BALANCE AT MARCH 31, 2020       754,000     $ 0.39  
  Granted       110,000       0.54  
  Forfeited/expired       (72,000 )     0.51  
  BALANCE AT MARCH 31, 2021       792,000     $ 0.40  


 

A summary of our stock option activity and related information for equity compensation plans not approved by security holders for the fiscal year ended March 31, 2021 is as follows:

 

          STOCK OPTIONS OUTSTANDING  
         

Number

Outstanding

      Weighted-Average Exercise Price per Share  
  BALANCE AT MARCH 31, 2019       294,000     $ 0.49  
  Forfeited/expired       (50,000 )     0.36  
  BALANCE AT MARCH 31, 2020       244,000     $ 0.52  
  Forfeited/expired       0       0.00  
  BALANCE AT MARCH 31, 2021       244,000     $ 0.52  

 

The following table summarizes information about employee stock options outstanding and exercisable at March 31, 2021:

 

          STOCK OPTIONS OUTSTANDING       STOCK OPTIONS EXERCISABLE  
  Range of Exercise Prices      

Number

Outstanding

      Weighted-Average Remaining Contractual Life (in Years)      

Weighted-Average Exercise Price

per Share

     

Number

Exercisable

     

Weighted-Average Exercise Price

per Share

 
  $0.30 - $0.35       550,000       2.3     $ 0.33       341,878     $ 0.32  
  $0.38 - $0.50       431,000       2.2     $ 0.43       226,056     $ 0.42  
  $0.54 - $0.67       55,000       4.9     $ 0.59       7,700     $ 0.55  
          1,036,000       2.4     $ 0.39       575,634     $ 0.36  

 

The 1,036,000 options outstanding as of March 31, 2021 are nonqualified stock options. The exercise price of all options granted through March 31, 2021 has been equal to or greater than the fair market value, as determined by our Board of Directors or based upon publicly quoted market values of our common stock on the date of the grant.